Lineage Cell Therapeutics Inc
TASE:LCTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lineage Cell Therapeutics Inc
TASE:LCTX
|
US |
|
D
|
Doosan Robotics Inc
KRX:454910
|
KR |
|
Inovio Pharmaceuticals Inc
NASDAQ:INO
|
US |
|
Pharnext SCA
OTC:PNEXF
|
FR |
|
Kearny Financial Corp
NASDAQ:KRNY
|
US |
|
Central Security Patrols Co Ltd
TSE:9740
|
JP |
|
G
|
Greencoat Renewables PLC
ISEQ:GRP
|
IE |
|
B
|
BORETECH Resource Recovery Engineering Co Ltd
TWSE:6887
|
CN |
|
Mitsubishi Corp
TSE:8058
|
JP |
|
Stewart Information Services Corp
NYSE:STC
|
US |
|
Rexford Industrial Realty Inc
NYSE:REXR
|
US |
|
National Vision Holdings Inc
NASDAQ:EYE
|
US |
|
Targa Resources Corp
NYSE:TRGP
|
US |
|
ASGN Inc
NYSE:ASGN
|
US |
|
K
|
Kumba Iron Ore Ltd
JSE:KIO
|
ZA |
|
JAFCO Group Co Ltd
TSE:8595
|
JP |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
H & R Block Inc
NYSE:HRB
|
US |
Bankruptcy Probability
Lineage Cell Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Lineage Cell Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
L
|
Lineage Cell Therapeutics Inc
TASE:LCTX
|
280.8m ILS |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
381.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
183.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Lineage Cell Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Lineage Cell Therapeutics Inc has total debt of 32k USD. This includes both short-term (0 USD) and long-term (32k USD) debt.
You can find a full breakdown on its Balance Sheet.
